 |
|
Regression of esophageal varices during entecavir treatment in patients with hepatitis-B-virus-related liver cirrhosis
Hye Young Jwa, Yoo-Kyung Cho, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong, Bong Soo Kim, Byoung-Wook Lee, Byung-Cheol Song
Clin Mol Hepatol. 2016;22(1):183-187. Published online 2016 Mar 28 DOI: https://doi.org/10.3350/cmh.2016.22.1.183
|
|
Citations to this article as recorded by
 Pathophysiology and Management of Variceal Bleeding
Saleh A. Alqahtani, Sunguk Jang
Drugs.2021; 81(6): 647. CrossRef Antiviral therapy reduces rebleeding rate in patients with hepatitis B-related cirrhosis with acute variceal bleeding after endotherapy
Lingling He, Xiaohui Ye, Jiali Ma, Ping Li, Yu Jiang, Julong Hu, Junru Yang, Yuling Zhou, Xiuxia Liang, Yijun Lin, Hongshan Wei
BMC Gastroenterology.2019;[Epub] CrossRef The noninvasive diagnosis of esophageal varices and its application in clinical practice
Etienne Pateu, Frédéric Oberti, Paul Calès
Clinics and Research in Hepatology and Gastroenterology.2018; 42(1): 6. CrossRef Small Esophageal Varices in Patients with Cirrhosis—Should We Treat Them?
Thomas Reiberger, Theresa Bucsics, Rafael Paternostro, Nikolaus Pfisterer, Florian Riedl, Mattias Mandorfer
Current Hepatology Reports.2018; 17(4): 301. CrossRef
|